Early Career Award
Dr. Ryan Denu, MD, PhD
MD Anderson Cancer Center · Houston, Texas
Recognizing and supporting the next generation of leiomyosarcoma researchers
Nominations due

Honoring leaders for their collaboration, dedication, and vision in driving forward sarcoma research and transforming patient outcomes.

Early Career Award
MD Anderson Cancer Center · Houston, Texas
Brian Van Tine, MD Memorial — Peer Recognition Award for Excellence in LMS Research
German Cancer Research Center · Heidelberg, Germany
Early Career Award
2024 Awardee
Nominations open — deadline extended to
Submit your completed nomination form directly to the Foundation (see How to Nominate below).
April 4, 2026 Announcement
The National Leiomyosarcoma Foundation (NLMSF) is offering an Early Career Award Program, currently in its 3rd year, to recognize and support Residents, Research Fellows, Post Docs, and Junior Investigators to develop specific interest in leiomyosarcoma research as a future focus in clinical practice and research endeavors.
One selected candidate per year is sponsored to attend the International LMS Research Roundtable, participate in one of the workgroups, and receive mentorship from participating scientific leadership.
The selected candidate will be acknowledged at the annual meeting of the International LMS Research Roundtable on October 2–3, 2026 in Milan, with sponsorship supporting their attendance and workgroup participation.
Sponsorship
Travel & attendance
Roundtable meeting
Oct 2–3, 2026
Location
Milan, Italy
Workgroups focus on setting goals and objectives centered around the unmet needs of LMS research and treatment. An example of work produced by the Clinical Trials Workgroup is reflected in this publication: PMC7924026.
Nominations are requested at this time. Please forward your completed nomination form to:
For questions or additional clarification, please contact Dr. Sujana Movva (movvas@mskcc.org), Medical Oncology, Sarcoma Center, Memorial Sloan Kettering — or Annie Achee, President of the National Leiomyosarcoma Foundation.